Lantheus Holdings

64 articles about Lantheus Holdings

• Lantheus Holdings Announces Senior Leadership Appointment - Jan. 27, 2020

  1/27/2020

  Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, announced the appointment of Paul Blanchfield as Chief Commercial Officer, effective January 27, 2020.

• Lantheus Holdings Announces Senior Leadership Appointment

  1/13/2020

  Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc., a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, announced the appointment of Istvan Molnar, M.D. as Chief Medical Officer, effective January 6, 2020.

• Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference

  11/21/2019

  Lantheus Holdings, Inc. announced Mary Anne Heino, President and Chief Executive Officer, will participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference at 9:30 a.m. ET on Thursday, December 5 in New York.

• Lantheus Releases Comprehensive Strategic Plan for Progenics

  11/7/2019

  Lantheus’ Value-Creating Vision for Integrating and Executing Transaction is Best Path Forward for Progenics

• Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference

  10/29/2019

  Lantheus Holdings, Inc. announced Mary Anne Heino, President and Chief Executive Officer, will present at the Credit Suisse 28th Annual Healthcare Conference at 3:35 p.m. MT on Tuesday, November 12 at The Phoenician in Scottsdale, AZ.

• Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time

  10/17/2019

  Lantheus Holdings, Inc. announced that it will host a conference call at 8:00 a.m.

• PROGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Progenics Pharmaceuticals, Inc. - PGNX

  10/3/2019

  Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Progenics Pharmaceuticals, Inc. (NasdaqGS: PGNX) to Lantheus Holdings, Inc.

• Velan Comments on Announced Sale of Progenics to Lantheus

  10/2/2019

  Believes Company’s Board has Abandoned its Fiduciary Duties by Choosing to Sell Progenics at Massive Discount in Attempt to Prevent the Voices of Shareholders from Being Heard

• Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company

  10/2/2019

  Highly Complementary Portfolio of Ultrasound and Radiopharmaceutical Diagnostics and Oncology Therapeutics

• Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference

  8/22/2019

  Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced it will be presenting at the Wells Fargo Securities 2019 Healthcare Conference on Thursday, September 5 at the Westin Copley Place in Boston.

• Lantheus Holdings Reports 2017 Third Quarter Financial Results; Exceeds Third Quarter and Raises Full-Year 2017 Guidance

  11/3/2017

  The Company’s worldwide revenues for the third quarter of 2017 totaled $79.9 million.

• Lantheus Holdings to Host Third Quarter 2017 Earnings Conference Call on November 2, 2017 at 4:30 p.m. Eastern Time

  10/20/2017

  Lantheus Holdings today announced that it will host a conference call at 4:30 p.m. ET on Thursday, November 2, 2017, to discuss its financial and operating results for the third quarter of 2017.

• Lantheus Holdings Reports 2017 Second Quarter Financial Results; Exceeds Second Quarter And Raises Full-Year 2017 Guidance

  8/2/2017

• Lantheus Holdings To Host Second Quarter 2017 Earnings Conference Call On August 1, 2017 At 4:30 P.M. Eastern Time

  7/19/2017

• Lantheus Holdings Announces Public Secondary Offering By Selling Stockholders Of 3,000,000 Shares Of Common Stock

  6/15/2017

• Lantheus Holdings Announces Public Secondary Offering By Selling Stockholders Of 3,000,000 Shares Of Common Stock

  6/15/2017

• Lantheus Holdings Announces Public Secondary Offering By Selling Stockholders Of 3,000,000 Shares Of Common Stock

  5/4/2017

• Lantheus Holdings Reports 2017 First Quarter Financial Results; Exceeds First Quarter And Raises Full-Year 2017 Guidance

  5/3/2017

• Lantheus Holdings And GE Healthcare Announce The Signing Of A Definitive License Agreement For Worldwide Development And Commercialization Of Flurpiridaz F 18

  4/25/2017

• Lantheus Holdings To Host First Quarter 2017 Earnings Conference Call On May 2, 2017 At 4:30 P.M. Eastern Time

  4/19/2017